Please sign in to follow a disease.
Pure red-cell aplasia
MONDO:0001705A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia, and selective erythroid hypoplasia.
Also known as: PRCA, Pure Red Cell Aplasia, Acquired, pure red cell aplasia
33 clinical trials for this condition and its sub-types, 5 tagged with Pure red-cell aplasia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Pure red-cell aplasia
-
Diamond-Blackfan anemia 17 trials
22 sub-types
- Diamond-Blackfan anemia 1 1 trial
- Diamond-Blackfan anemia 10 0 trials
- Diamond-Blackfan anemia 11 0 trials
- Diamond-Blackfan anemia 12 0 trials
- Diamond-Blackfan anemia 13 0 trials
- Diamond-Blackfan anemia 14 with mandibulofacial dysostosis 0 trials
- Diamond-Blackfan anemia 15 with mandibulofacial dysostosis 0 trials
- Diamond-Blackfan anemia 16 0 trials
- Diamond-Blackfan anemia 17 0 trials
- Diamond-Blackfan anemia 18 0 trials
- Diamond-Blackfan anemia 19 0 trials
- Diamond-Blackfan anemia 2 0 trials
- Diamond-Blackfan anemia 20 0 trials
- Diamond-Blackfan anemia 21 0 trials
- Diamond-Blackfan anemia 22 0 trials
- Diamond-Blackfan anemia 3 0 trials
- Diamond-Blackfan anemia 4 0 trials
- Diamond-Blackfan anemia 5 0 trials
- Diamond-Blackfan anemia 6 0 trials
- Diamond-Blackfan anemia 7 0 trials
- Diamond-Blackfan anemia 8 0 trials
- Diamond-Blackfan anemia 9 0 trials
-
Adult pure red cell aplasia 2 trials
-
New stem cell method aims to cut transplant risks
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with severe aplastic anemia or other bone marrow failure diseases. Doctors give a smaller number of donor white blood cells along with the stem cells to try to reduce serious side effects. Up to 120 patients aged 4…
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for kids with sickle cell: stem cell transplant from mismatched blood type donors
Disease control Recruiting nowThis study tests a stem cell transplant for children with sickle cell disease who have a matched family donor whose blood type is incompatible. The goal is to see if a gentle conditioning regimen using alemtuzumab, low-dose radiation, and sirolimus can safely allow the transplant…
Phase 2 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC